Insider Trading History of Moore John R

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Moore John R since 2015. This trader's CIK number is 1191702. At the time of last reporting, Moore John R was the General Counsel of Edgewise Therapeutics, Inc.. (stock ticker symbol EWTX). Also see all insider trading activities at Edgewise Therapeutics, Inc..

Note that in the past MOORE JOHN R also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Edgewise Therapeutics, Inc. (EWTX) by Moore John R

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 EWTX 0 $0 4,028 $59,852 10,990 $0
2024 EWTX 0 $0 102,713 $2,630,367 105,965 $107,934
2023 EWTX 0 $0 10,394 $106,110 5,208 $0
2022 EWTX 0 $0 202,895 $1,385,725 197,495 $279,815
2021 EWTX 0 $0 0 $0 5,400 $3,834

Yearly summary of insider trading at Array Biopharma Inc (ARRY) by Moore John R

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2017 ARRY 0 $0 0 $0 6,718 $0
2015 ARRY 0 $0 0 $0 22,906 $182,331


Insider trading activities at 2 companies by Moore John R:

1. Edgewise Therapeutics, Inc. (EWTX)

2. Array Biopharma Inc (ARRY)

Table 1. Insider trading of Edgewise Therapeutics, Inc. (EWTX) by Moore John R

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-08-12 EWTX Option Ex 5,781 .00 0
2025-08-12 EWTX Sale 2,098 13.39 28,096
2025-05-01 EWTX Option Ex 5,209 .00 0
2025-05-02 EWTX Sale 1,930 16.45 31,756
2024-09-23 EWTX Sale 20,922 27.63 578,074
2024-09-23 EWTX Option Ex 20,922 .71 14,854
2024-09-20 EWTX Sale 50,000 28.37 1,418,500
2024-09-20 EWTX Option Ex 50,000 .71 35,500
2024-05-02 EWTX Sale 1,956 18.91 36,987
2024-05-01 EWTX Option Ex 5,208 .00 0
2024-02-09 EWTX Sale 8,029 20.01 160,660
2024-02-08 EWTX Sale 3,813 20.01 76,286
2024-02-09 EWTX Option Ex 8,029 1.93 15,495
2024-02-07 EWTX Sale 17,993 20.00 359,860
2024-02-08 EWTX Option Ex 3,813 1.93 7,359
2024-02-07 EWTX Option Ex 17,993 1.93 34,726
2023-12-27 EWTX Sale 8,497 10.50 89,218
2023-05-01 EWTX Option Ex 5,208 .00 0
2023-05-02 EWTX Sale 1,897 8.90 16,892
2022-10-03 EWTX Option Ex 4,730 1.93 9,128
2022-10-03 EWTX Sale 4,730 9.76 46,155
2022-08-03 EWTX Sale 9,232 9.31 85,922
2022-08-03 EWTX Option Ex 9,232 1.32 12,186
2022-07-05 EWTX Option Ex 8,186 1.32 10,805
2022-07-06 EWTX Option Ex 1,046 1.93 2,018
2022-07-05 EWTX Sale 8,186 8.35 68,328
2022-07-06 EWTX Sale 1,046 8.54 8,927
2022-06-16 EWTX Sale 14,722 6.17 90,805
2022-06-17 EWTX Sale 22,127 6.62 146,436
2022-06-21 EWTX Option Ex 31,078 1.32 41,022
2022-06-21 EWTX Sale 31,078 7.29 226,682
2022-06-16 EWTX Option Ex 14,722 1.93 28,413
2022-06-17 EWTX Option Ex 22,127 1.93 42,705
2022-06-15 EWTX Sale 18,660 6.11 114,012
2022-06-14 EWTX Sale 3,628 6.02 21,855
2022-06-15 EWTX Option Ex 18,660 1.32 24,631
2022-06-14 EWTX Option Ex 3,628 .71 2,575
2022-06-13 EWTX Sale 4,093 6.01 24,582
2022-06-13 EWTX Option Ex 4,093 .71 2,906
2022-06-10 EWTX Sale 7,125 6.05 43,120
2022-06-09 EWTX Sale 7,615 6.49 49,398
2022-06-08 EWTX Sale 12,566 6.63 83,362
2022-06-10 EWTX Option Ex 7,125 .71 5,058
2022-06-09 EWTX Option Ex 7,615 .71 5,406
2022-06-08 EWTX Option Ex 12,566 .71 8,921
2022-06-03 EWTX Sale 15,230 6.05 92,202
2022-06-03 EWTX Option Ex 15,230 1.93 29,393
2022-06-07 EWTX Sale 18,123 6.61 119,702
2022-06-06 EWTX Sale 13,934 6.04 84,091
2022-06-07 EWTX Option Ex 18,123 1.32 23,922
2022-06-06 EWTX Option Ex 13,934 1.93 26,892
2022-05-16 EWTX Sale 10,800 7.42 80,146
2022-01-21 EWTX Option Ex 5,400 .71 3,834
2021-12-28 EWTX Option Ex 5,400 .71 3,834

Table 2. Insider trading of Array Biopharma Inc (ARRY) by Moore John R

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2017-04-01 ARRY Option Ex 6,718 .00 0
2015-03-01 ARRY Option Ex 22,906 7.96 182,331

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Moore John R (General Counsel of Edgewise Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.